Glossary
Absolute risk reduction
See risk difference.
Allocation concealment
See concealment of
allocation.
Applicability
(synonyms: external validity,
generalisability, relevance, transferability)
The degree to which the results of an observation, study or review hold
true in other settings.
Attrition bias
Systematic differences between
comparison groups in withdrawals or exclusions of participants from the results
of a study. For example, patients may drop out of a study because of side
effects of the intervention. Excluding these patients from the analysis could
result in an overestimate of the effectiveness of the intervention.
Bias
A systematic error or deviation in results
or inferences. In studies of the effects of healthcare, bias can arise from
systematic differences in the groups that are compared (selection bias), the
care that is provided, or exposure to other factors apart from the intervention
of interest (performance bias), withdrawals or exclusions of people entered
into the study (attrition bias) or how outcomes are assessed (detection bias).
Bias does not necessarily imply a prejudice, such as the investigators' desire
for particular results. This differs from conventional use of the word in which
bias refers to a partisan point of view. See also methodological quality,
validity.
Blinding
(synonym: masking) Keeping
secret group assignment (e.g. to treatment or control) from the study
participants or investigators. Blinding is used to protect against the
possibility that knowledge of assignment may affect patient response to
treatment, provider behaviours (performance bias) or outcome assessment
(detection bias). Blinding is not always practical (e.g. when comparing surgery
to drug treatment). The importance of blinding depends on how objective the
outcome measure is; blinding is more important for less objective outcome
measures such as pain or quality of life. See also single blind, double blind
and triple blind.
Case series
An uncontrolled observational study
involving an intervention and outcome for more than one person.
Case study
(synonyms: anecdote, case history,
single case report) An uncontrolled observational study involving an
intervention and outcome for a single person (or other unit).
CCTR
See Cochrane Controlled Trials Register.
CDSR
See Cochrane Database of Systematic Reviews.
CENTRAL
The Cochrane Collaboration's register of
studies which may be relevant for inclusion in Cochrane Reviews. Its
development is guided by the CENTRAL/CCTR Advisory Group. See also Cochrane
Controlled Trials Register.
Chi-square test
Any statistical test based on
comparison of a test statistic to a chi-square distribution.
CI
See Confidence interval
CINAHL
(Cumulative Index of Nursing and Allied
Health Literature) Electronic database covering the major journals in
nursing and allied health. Years of coverage: 1983 - present.
Clinical guideline
A systematically developed
statement for practitioners and patients about appropriate health care for
specific clinical circumstances. (e.g. Scottish Intercollegiate or SIGN
guidelines, Royal College of Physicians guidelines etc.)
Clinical trial
(synonyms: therapeutic trial,
intervention study) A trial that tests out a drug or other
intervention to assess its effectiveness and safety. This general term
encompasses randomised controlled trials and controlled clinical trials.
Cochrane Collaboration
An international
organisation that aims to help people make well informed decisions about health
by preparing, maintaining and ensuring the accessibility of systematic reviews
of the benefits and risks of healthcare interventions.
Cochrane Controlled Trials Register
(CCTR)
A database of references to controlled trials in health care. Cochrane groups
and other organisations have been invited to contribute their specialised
registers, and these registers, together with references to clinical trials
identified on MEDLINE and other sources, form the CENTRAL register of studies.
Records from CENTRAL, following quality control to try to ensure that only
reports of definite randomised controlled trials or controlled clinical trials
are included, make up The Cochrane Controlled Trials Register (CCTR). Trials
included in the STEP process are derived from the Cochrane Stroke Group.
Cochrane Database of Systematic Reviews
(CDSR)
It brings together all the currently available Cochrane Reviews and is updated
quarterly.
Cochrane Review
A Cochrane Review is a
systematic, up-to-date summary of reliable evidence of the benefits and risks
of healthcare. Cochrane Reviews are intended to help people make practical
decisions.
Cointervention
In a randomised controlled trial,
the application of additional diagnostic or therapeutic procedures to members
of either or both the experimental and the control groups.
Concealment of allocation
The process used to
prevent foreknowledge of group assignment in a randomised controlled trial,
which should be seen as distinct from blinding. The allocation process should
be impervious to any influence by the individual making the allocation by
having the randomisation process administered by someone who is not responsible
for recruiting participants; for example, a hospital pharmacy, or a central
office. Using methods of assignment such as date of birth and case record
numbers (see quasi random allocation) are open to manipulation. Adequate
methods of allocation concealment include: centralized randomisation schemes;
randomisation schemes controlled by a pharmacy; numbered or coded containers in
which capsules from identical-looking, numbered bottles are administered
sequentially; on-site computer systems, where allocations are in a locked
unreadable file; and sequentially numbered opaque, sealed envelopes.
Confidence interval
(CI) The range
within which the "true" value (e.g. size of effect of an intervention) is
expected to lie with a given degree of certainty (e.g. 95% or 99%). Note:
Confidence intervals represent the probability of random errors, but not
systematic errors (bias).
Conflict of interest declaration
[or Competing
interests declaration] A statement by a contributor to a report or
review of personal financial or other interests that could have influenced the
findings or their interpretation.
Confounding
A situation in which a measure of
the effect of an intervention or exposure is distorted because of the
association of exposure with other factor(s) that influence the outcome under
investigation.
Consumer
(healthcare consumer) Someone
who uses, is affected by, or who is entitled or compelled to use a health
related service.
Contamination
In clinical trials, the
unintentional application of the intervention being evaluated to people in the
control group or inadvertent failure to apply the intervention to people
assigned to the intervention group.
Context
The conditions and circumstances that
are relevant to the application of an intervention, for example the setting [in
hospital, at home, in the air], the time [working day, holiday, night-time],
type of practice [primary, secondary, tertiary care; private practice,
insurance practice, charity], whether routine or emergency.
Control
In clinical trials comparing two or more
interventions, a control is a person in the comparison group that receives a
placebo, no intervention, usual care or another form of care.
Controlled clinical trial
Refers to a study that
compares one or more intervention groups to one or more comparison (control)
groups. Whilst not all controlled studies are randomised, all randomised trials
are controlled.
Critical appraisal
The process of assessing and
interpreting evidence by systematically considering its validity, results and
relevance.
Cross-over trial
A type of clinical trial
comparing two or more interventions in which the participants, upon completion
of the course of one treatment are switched to another. For example, for a
comparison of treatments A and B, half the participants are randomly allocated
to receive them in the order A, B and half to receive them in the order B, A. A
problem with this design is that the effects of the first treatment may carry
over into the period when the second is given.
DARE
See Database of Abstracts of Reviews of
Effectiveness.
Database
A collection of organised information,
usually held on a computer. In some ways a database is similar to a filing
system, but with important advantages: the information can be revised and kept
up to date easily, and the computer can retrieve information from it very
quickly. Electronic databases such as MEDLINE, EMBASE and the CDSR can be
distributed on disk, CD-ROM or via the Internet.
Database of Abstracts of Reviews of Effectiveness
(DARE) A collection of structured abstracts and bibliographic
references of systematic reviews of the effects of healthcare.
Detection bias
(synonym: ascertainment bias)
Systematic differences between comparison groups in how outcomes are
ascertained, diagnosed or verified.
Dichotomous data
(synonym: binary data)
Observations with two possible categories such as dead/alive,
smoker/non-smoker, present/not present.
Double blind
(synonym: double masked) Neither
the participants in a trial nor the investigators (outcome assessors) are aware
of which intervention the participants are given. The purpose of blinding the
participants (recipients and providers of care) is to prevent performance bias.
The purpose of blinding the investigators (outcome assessors, who might also be
the care providers) is to protect against detection bias. See also blinding,
single blind, triple blind, concealment of allocation.
Effect size
1. A generic term for the estimate
of effect for a study. 2. A dimensionless measure of effect that is typically
used for continuous data when different scales (e.g. for measuring pain) are
used to measure an outcome and is usually defined as the difference in means
between the intervention and control groups divided by the standard deviation
of the control or both groups. See standardised mean difference.
Effectiveness
The extent to which a specific
intervention, when used under ordinary circumstances, does what it is intended
to do.
Efficacy